Legal Representation
Attorney
Gene K. Park
USPTO Deadlines
Application History
49 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Jan 8, 2024 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 8, 2024 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| Jun 7, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Jun 6, 2023 | EX5G | S | SOU EXTENSION 5 GRANTED | Loading... |
| Jun 2, 2023 | EXT5 | S | SOU EXTENSION 5 FILED | Loading... |
| Jun 2, 2023 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 22, 2023 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 21, 2023 | EX4G | S | SOU EXTENSION 4 GRANTED | Loading... |
| Dec 8, 2022 | EXT4 | S | SOU EXTENSION 4 FILED | Loading... |
| Apr 20, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Mar 2, 2023 | NREV | E | NOTICE OF REVIVAL - E-MAILED | Loading... |
| Mar 1, 2023 | TPEX | I | SOU EXTENSION RECEIVED WITH TEAS PETITION | Loading... |
| Mar 1, 2023 | PETG | O | PETITION TO REVIVE-GRANTED | Loading... |
| Mar 1, 2023 | PROA | I | TEAS PETITION TO REVIVE RECEIVED | Loading... |
| Mar 1, 2023 | CHAN | I | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED | Loading... |
| Mar 1, 2023 | TCCA | I | TEAS CHANGE OF CORRESPONDENCE RECEIVED | Loading... |
| Mar 1, 2023 | ARAA | I | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | Loading... |
| Mar 1, 2023 | REAP | I | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | Loading... |
| Mar 1, 2023 | COAR | I | TEAS CHANGE OF OWNER ADDRESS RECEIVED | Loading... |
| Jan 11, 2023 | ASGN | I | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP | Loading... |
| Jan 9, 2023 | MAB6 | E | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED | Loading... |
| Jan 9, 2023 | ABN6 | S | ABANDONMENT - NO USE STATEMENT FILED | Loading... |
| May 12, 2022 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| May 10, 2022 | EX3G | S | SOU EXTENSION 3 GRANTED | Loading... |
| May 10, 2022 | EXT3 | S | SOU EXTENSION 3 FILED | Loading... |
| May 10, 2022 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 1, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Nov 29, 2021 | EX2G | S | SOU EXTENSION 2 GRANTED | Loading... |
| Nov 29, 2021 | EXT2 | S | SOU EXTENSION 2 FILED | Loading... |
| Nov 29, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Apr 24, 2021 | EXRA | E | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | Loading... |
| Apr 22, 2021 | EX1G | S | SOU EXTENSION 1 GRANTED | Loading... |
| Apr 22, 2021 | EXT1 | S | SOU EXTENSION 1 FILED | Loading... |
| Apr 22, 2021 | EEXT | I | SOU TEAS EXTENSION RECEIVED | Loading... |
| Dec 8, 2020 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Oct 13, 2020 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Oct 13, 2020 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| Sep 23, 2020 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| Sep 10, 2020 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| Sep 8, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Sep 8, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Sep 3, 2020 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Aug 14, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Mar 31, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Mar 31, 2020 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Mar 31, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Mar 27, 2020 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Jan 14, 2020 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Jan 13, 2020 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 005
Pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Pharmaceutical preparations, namely, narcotic antagonists; Pharmaceutical preparations, namely, opioid antagonists; Syringes sold filled with pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Syringes sold filled with pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Syringes sold filled with narcotic antagonists; Syringes sold filled with opioid antagonists; Injectors sold filled with pharmaceutical preparations for use in the treatment of opioid overdose and addiction; Injectors sold filled with pharmaceutical preparations for use in the treatment of substance abuse disorders, addiction, and overdose; Injectors sold filled with narcotic antagonists; Injectors sold filled with opioid antagonists; Injectable pharmaceuticals for use in the treatment of opioid overdose and addiction; Injectable pharmaceuticals for use in the treatment of substance abuse disorders, addiction, and overdose; Injectable pharmaceuticals, namely, narcotic antagonists; Injectable pharmaceuticals, namely, opioid antagonists
Class 010
Syringes for pharmaceutical preparations; Injectors for pharmaceutical preparations; Syringes for medical purposes
Classification
International Classes
005
010